Effect of anti–tumor necrosis factor therapy on the risk of respiratory tract infections and related symptoms in patients with psoriasis—A meta-estimate of pivotal phase 3 trials relevant to decision making during the COVID-19 pandemic-Reference-Cited by-同舟云学术

Effect of anti–tumor necrosis factor therapy on the risk of respiratory tract infections and related symptoms in patients with psoriasis—A meta-estimate of pivotal phase 3 trials relevant to decision making during the COVID-19 pandemic

Published:2021-01 Issue:1 Volume:84 Page:161-163
ISSN:0190-9622
Container-title:Journal of the American Academy of Dermatology
language:en
Short-container-title:Journal of the American Academy of Dermatology

Author:

Syed Maha N.,Shah Mohsin,Shin Daniel B.,Wan Marilyn T.,Winthrop Kevin L.,Gelfand Joel M.

Funder

National Institutes of Health

Publisher

Elsevier BV

Subject

Dermatology

Reference5 articles.

1. The risk of respiratory tract infections and symptoms in psoriasis patients treated with IL-17-pathway inhibiting biologics: a meta-estimate of pivotal trials relevant to decision-making during the COVID-19 pandemic;Wan;J Am Acad Dermatol,2020

2. The risk of respiratory tract infections in psoriasis patients treated with IL-23-pathway inhibiting biologics: a meta-estimate of pivotal trials relevant to decision-making during the COVID-19 pandemic;Syed;J Am Acad Dermatol,2020

3. Trials of anti-tumour necrosis factor therapy for COVID-19 are urgently needed;Feldmann;Lancet,2020

4. Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry;Gianfrancesco;Ann Rheum Dis,2020

5. Ongoing clinical trials for the management of the COVID-19 pandemic;Lythgoe;Trends Pharmacol Sci,2020

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impacts of Inflammatory Cytokines Variants on Systemic Inflammatory Profile and COVID-19 Severity;Journal of Epidemiology and Global Health;2024-02-20

2. Advancements in the Study of Biologic Agents in Comorbidities of Psoriasis: A Literature Review;Clinical, Cosmetic and Investigational Dermatology;2023-12

3. The Impact of Immune-Modulating Treatments for Dermatological Diseases on the Risk of Infection with SARS-CoV-2 and Outcomes Associated with COVID-19 Illness;Current Dermatology Reports;2023-04-03

4. The human respiratory system and overview of respiratory diseases;Systems and Signal Processing of Capnography as a Diagnostic Tool for Asthma Assessment;2023

5. Use of biologics during the COVID-19 pandemic: lessons learned from psoriasis;Expert Opinion on Biological Therapy;2022-08-08